Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press119410.17650/1726-9776-2020-16-2-97-103DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCERДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыряMicrobiota/microbiome urine and bladder cancerМикробиота/микробиом мочи и рак мочевого пузыряhttps://orcid.org/0000-0002-1710-0169KoganM. I.КоганМ. И.
Russian Federation

29 Nakhichevanskiy Pereulok, Rostov-on-Don 344022

Михаил Иосифович Коган

344022 Ростов-на-Дону, Нахичеванский переулок, 29

https://orcid.org/0000-0002-0937-4573NabokaYu. L.НабокаЮ. Л.
Russian Federation

29 Nakhichevanskiy Pereulok, Rostov-on-Don 344022

344022 Ростов-на-Дону, Нахичеванский переулок, 29

https://orcid.org/0000-0001-7035-5665RyzhkinA. V.РыжкинА. В.
Russian Federation

29 Nakhichevanskiy Pereulok, Rostov-on-Don 344022

Андрей Вячеславович Рыжкин

344022 Ростов-на-Дону, Нахичеванский переулок, 29

slip161@yandex.ruhttps://orcid.org/0000-0001-5642-4521VasilyevO. N.ВасильевО. Н.
Russian Federation

29 Nakhichevanskiy Pereulok, Rostov-on-Don 344022

344022 Ростов-на-Дону, Нахичеванский переулок, 29

Rostov State Medical University, Ministry of Health of RussiaФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава России30062020162971031902202002052020https://oncourology.abvpress.ru/oncur/article/view/1194

The aim of the review was to systematize the evidence available in the world literature on the influence of the role of microbiota and urinary microbiome on the development of bladder cancer. Given the constant development of medical technologies, patient examination algorithms, an obligate range of diagnostic tools, and the appropriateness of using the latest laboratory techniques are being reviewed.

Цель обзора — суммарная систематизация имеющихся в мировой литературе свидетельств влияния роли микробиоты и микро-биома мочи на развитие рака мочевого пузыря. С учетом постоянного развития медицинских технологий подвергаются пересмотру алгоритмы обследования пациентов, облигатный спектр диагностических средств, а также целесообразность использования новейших лабораторных методик.

urinary tractmicrobiotamicrobiomepyrosequencingbladder cancermicrobiological methodмочевыводящий путьмикробиотамикробиомпиросеквенированиерак мочевого пузырямикробиологический методMalignant tumors in Russia in 2016 (morbidity and mortality). Eds.: A.D. Kaprin, VV Starin-skiy, G.V. Petrova. Moscow: MNIOI im. PA. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2018. 250 p. (In Russ.).Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. 250 с.Richters A., Aben K.K.H., Kiemeney L.A. The global burden of urinary bladder cancer: an update. World J Urol 2019. DOI: 10.1007/s00345-019-02984-4.Babjuk M., Bohle A., Burger M. et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71(3):447-61. DOI: 10.1016/j.eururo.2016.05.041.Costello E.K., Stagaman K., Dethlefsen L. et al. The application of ecological theory toward an understanding of the human mi-crobiome. Science 2012;336(6086):1255—62. DOI: 10.1126/science.1224203.Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118(12):3030—44. DOI: 10.1002/ijc.21731.Shiff C., Veltri R., Naples J. et al. Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schitosoma haematobium in Ghana. Trans R Soc Trop Med Hyg 2003;100(9):847—57. DOI: 10.1016/j.trstmh.2005.10.010.Zaghloul M.S. Bladder cancer and schistosomiasis. J Egypt Natl Cancer Inst 2012;24(4):151—9. DOI: 10.1016/j.jnci.2012.08.002.Bicher K.H., Feil G., Zumbragel A. et al. Shstomiasis: a critical review. Curr Opin Urol 2001;11(1):97—101. DOI: 10.1097/00042307-200101000-00015.IARC Monographs on the evaluation of carcinogenic risks to humans. Biological Agents 2012;100B:35—44.Jnrgensen K.R., Jensen J.B. Human papillomavirus and urinary bladder cancer revisited. APMIS 2020;128(2):72—9. DOI: 10.1111/apm.13016.Simoneau M., LaRue H., Fradet Y. Low frequency of human papillomavirus infection in initial papillary bladder tumors. Urol Res 1999;27(3):180—4. DOI: 10.1007/s002400050107.Shigehara K., Sasagawa T., Kawaguchi S. et al. Etiologic role of human papillomavirus infection in bladder carcinoma. Cancer 2011;117(10):2067—76. DOI: 10.1002/cncr.25777.Pichler R., Borena W., Schafer G. et al. Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot. World J Urol 2015;33(12):2145—51. DOI: 10.1007/s00345-015-1539-yJnrgensen K.R., Hnyer S., Jakobsen J.K. et al. Human papillomavirus and squamous cell carcinoma of the urinary bladder: DaBlaCa-10 study. Scand J Urol 2018;52(5—6):371—6. DOI: 10.1080/21681805.2018.1531920.Li N., Yang L., Zhang Y. et al. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis 2011;204(2):217—23. DOI: 10.1093/infdis/jir248.Dzutsev A., Goldszmid R.S., Viaud S. et al. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol. 2015;45(1):17—31. DOI: 10.1002/eji.201444972.Roy S., Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer 2017;17(5):271—85. DOI: 10.1038/nrc.2017.13.De Martel C., Ferlay J., Franceschi S. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13(6):607—15. DOI: 10.1016/S1470-2045(12)70137-7.Garrett W.S. Cancer and the microbiota. Science 2015;3;348(6230):80—6. DOI: 10.1126/science.aaa4972.NIH HMP Working Group, Peterson J., Garges S. et al. The NIH Human Microbiome Project. Genome Res 2009;19(12):2317—23. DOI: 10.1101/gr.096651.109.Brawner K.M., Morrow C.D., Smith P.D. Gastric microbiome and gastric cancer. Cancer J 2014;20(3):211—6. DOI: 10.1097/PPO.0000000000000043.Arends M.J. Pathways of colorectal carcinogenesis. Appl Immunohistochem Mol Morphol 2013;21(2):97—102. DOI: 10.1097/PAI.0b013e31827ea79e.Rubinstein M.R., Wang X., Liu W. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14(2):195—206. DOI: 10.1016/j.chom.2013.07.012.Aso Y., Akaza H., Kotake T. et al. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. BLP Stud Group Eur Urol 1995;27(2):104—9. DOI: 10.1159/000475138.Ohashi Y., Nakai S., Tsukamoto T. et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 2002;68(4):273—80. DOI: 10.1159/000058450.O’Donnell M.A. Does the probiotic L. ca-sei help prevent recurrence after transurethral resection for superficial bladder cancer? Nat Clin Pract Urol 2008;5(10):526—7. DOI: 10.1038/ncpuro1199.Hoesl C.E., Altwein J.E. The probiotic approach: an alternative treatment option in urology. Eur Urol 2005;47(3):288—96. DOI: 10.1016/j.eururo.2004.09.011.Monachese M., Burton J.P., Reid G. Bioremediation and tolerance of humans to heavy metals through microbial processes: a potential role for probiotics? Appl Environ Microbiol 2012;78(18):6397—404. DOI: 10.1128/AEM.01665-12.Bajic P, Wolfe A.J., Gupta G.N. The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics. Urology 2019;126:10—5 DOI: 10.1016/j.urology.2018.12.034.Kopeyka A.A., Savitskaya K.I., Ponomar V.K. et al. Characterization of bacteriuria in some urological diseases. Urologiya i nefrologiya = Urology and Nephrology 1995;(4):12—3. (In Russ.).Копейка А.А., Савицкая К.И., Пономарь В.К. и др. Характеристика бакте-риурии при некоторых урологических заболеваниях. Урология и нефрология 1995;(4):12—3.Derevyanko I.I., Kotlyaro-va G.A., Kondratyev E.M. et al. The etiological structure of inflammatory non-specific diseases and the dynamics of their resistance to widely used antibiotics. Urologiya i nefrologiya = Urology and Nephrology 1997;(3):3—8. (In Russ.).Деревянко И.И., Котлярова Г.А., Кондратьева Е.М. и др. Этиологическая структура воспалительных неспецифических заболеваний и динамика их резистентности к широко применяемым антибиотикам. Урология и нефрология 1997;(3):3—8.Hilt E.E., McKinley K., Pearce M.M. et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 2.014;52(3):871—6. DOI: 10.1128/JCM.02876-13.Madigan M.T., Martinko J.M., Stahl D. et al. Brock Biology of Microorganisms (13th Edition). San Francisco: Pearson education, 2012.Naboka Yu.L. Characterization of dysbiotic changes in the microflora of the large intestine, palatine tonsils and urinary tract with pyelonephritis in children. Izvestiya vysshikh uchebnykh zavedeniy. Severo-Kavkazskiy region. Estestvennye nauki = Bulletin of higher educational institutions. North Caucasus region. Natural Sciences 2004;10:83-91. (In Russ.).Набока Ю.Л. Характеристика дисбио-тических изменений микрофлоры толстого кишечника, небных миндалин и мочевыводящих путей при пиелонефрите у детей. Известия высших учебных заведений. Северо-Кавказский регион. Естественные науки 2004;10:83-91.Naboka Yu.L. The etiological structure of acute pyelonephritis in children. Vestnik Orenburgskogo gosudarstvennogo universiteta = Bulletin of the Orenburg State University 2005;5:31-4. (In Russ.).Набока Ю.Л. Этиологическая структура острого пиелонефрита у детей. Вестник Оренбургского государственного университета 2005;5:31-4. [Naboka Yu.L.Naboka Yu.L., Kogan M.I., Gudima I.A. et al. The role of non-clostridial anaerobes in the development of infectious and inflammatory diseases of the urinary and reproductive organs. Urologiya = Urology 2013;(6):118—21. (In Russ.).Набока Ю.Л., Коган М.И., Гудима И.А. и др. Роль неклостридиальных анаэробов в развитии инфекционно-воспалительных заболеваний органов мочевой и половой систем. Урология 2013;(6):118—21.Khasriya R., Sathiananthamoorthy S., Ismail S. et al. Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol 2013;51(7):2054—62. DOI: 10.1128/JCM.03314-12.Zverev V.V., Bykov A.S. Medical Microbiology, Virology and Immunology. Moscow: MIA, 2016. 816 p. (In Russ.).Зверев В.В., Быков А.С. Медицинская микробиология, вирусология и иммунология. М.: МИА, 2016. 816 с.Siddiqui H., Nederbragt A.J., Lagesen K. et al. Assesing diversity of the female urine microbiota by high throughput sequencing of 16S RNA amplicons. BMC Microbiol 2011;11:244. DOI: 10.1186/1471-2180-11-244.Wolfe A.J., Toh E., Shibata N. et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 2012;50(4):1376-83. DOI: 10.1128/JCM.05852-11.Pearce M.M., Hilt E.E., Rosenfeld A.B. et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 2014;5(4):e01283-14. DOI: 10.1128/mBio.01283-14.Karstens L., Asquith M., Davin S. et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol 2016;6:78. DOI: 10.3389/fcimb.2016.00078.Mulvey M.A., Klumpp D.J., Stapleton A.E. Urinary tract infections: molecular pathogenesis and clinical management. Washington, 2017. P. 550.Dong Q., Nelson D.E., Toh E. et al. The microbial communities in male first urine are highly similar to those in paired urethral swab specimens. PLoS One 2011;6(5):e19709. DOI: 10.1371/journal.pone.0019709.Nelson D.E., Dong Q., Van der Pol B. et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One 2012;7(5):e36298. DOI: 10.1371/journal.pone.0036298.Naboka Yu.L. Microbial spectrum of biopsy samples of kidneys and intraoperative urine in children with obstructive urological pathology. Sibir’-Vostok Vserossiyskiy meditsinskiy nauchno-proizvodstvennyy zhurnal = Siberia-East All-Russian Medical Scientific and Production Journal 2005;3:17-9. (In Russ.).Набока Ю.Л. Микробный спектр био-птатов почек и интраоперационной мочи у детей с обструктивной урологической патологией. Сибирь-Восток Всероссийский медицинский научнопроизводственный журнал 2005;3:17-9.Kogan M.I., Naboka Yu.L., Vasilyeva L.I. et al. Etiological structure and antibiotic sensitivity of pathogens of acute non-obstructive pyelonephritis in children. Lechashchij vrach = Attending Doctor 2009;(8):8-11. (In Russ.).Коган М.И., Набока Ю.Л., Васильева Л.И. и др. Этиологическая структура и антибиотикочувствительность возбудителей острого необструктивного пиелонефрита у детей. Лечащий врач 2009;(8):8-11.Glybochko P.V., Kogan M.I., Naboka Yu.L. Infections and inflammations in urology. Moscow: Medforum-Alfa, 2019. Pp. 18-19. (In Russ.).Глыбочко П.В., Коган М.И., Набока Ю.Л. Инфекции и воспаления в урологии. М.: Медфорум-Альфа, 2019. C. 18-19.Price T.K., Dune T., Hilt E.E. et al. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol 2016;54(5):1216—22. DOI: 10.1128/JCM.00044-16.Herr H.W., Morales A. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol 2008;179(1):53-6. DOI: 10.1016/j.juro.2007.08.122.McMillan A., Macklaim J.M., Burton J.P., Reid G. Adhesion of Lactobacillus iners AB-1 to human fibronectin: a key mediator for persistence in the vagina? Reprod Sci 2013;20(7):791—6. DOI: 10.1177/1933719112466306.Seow S.W., Rahmat J.N., Bay B.H. et al. Expression of chemokine/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guerin or Lactobacillus rhamnosus strain GG in the healthy murine bladder. Immunology 2008;124(3):419—27. DOI: 10.1111/j.1365-2567.2007.02792.x.Xu W., Yang L., Lee P. et al. Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma. Am J Clin Exp Urol 2014;2(1):57-61.Wu P., Zhang G., Zhao J. et al. Profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect Microbiol 2018;8:167. DOI: 10.3389/fcimb.2018.00167.Schwabe R.F., Jobin C. The microbiome and cancer. Nat Rev Cancer 2013;13(11): 800-12. DOI: 10.1038/nrc3610.Bucevic Popovic V., Situm M., Chow C.T. et al. The urinary microbiome associated with bladder cancer. Sci Rep 2018;8(1):12157. DOI: 10.1038/s41598-018-29054-w.Bi H., Tian Y., Huang Y., Zhang Y. Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer. Eur Urol Suppl 2019;18(1):e1462. DOI: 10.1016/s1569-9056(19)31053-x.Fok C.S., McKinley K., Mueller E.R. et al. Day of surgery urine cultures identify urogynecologic patients at increased risk for postoperative urinary tract infection. J Urol 2013;189(5):1721 —4. DOI: 10.1016/j.juro.2012.11.167.Bajic P., van Kuiken M.E., Burge B.K. et al. Male bladder microbiome relates to lower urinary tract symptoms. Eur Urol Focus 2020;6(2):376-82. DOI: 10.1016/j.euf.2018.08.001.Matson V., Fessler J., Bao R. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 2018;359(6371): 104-8. DOI: 10.1126/science.aao3290.Vetizou M., Trinchieri G. Anti-PD1 in the wonder-gut-land. Cell Res 2018;28(3):263-4. DOI: 10.1038/cr.2018.12.Patel J., Crawford J.M. Microbiota-regulated outcomes of human cancer immunotherapy via the PD-1/PD-L1 axis. Biochemistry 2018;57(6):901—3. DOI: 10.1021/acs.biochem.7b01249.